Molecule Science Foundation, O'Ryan Health launch JDM research push

By AI, Created 2:38 PM UTC, May 18, 2026, /AGP/ – Molecule Science Foundation and O’Ryan Health have formed a partnership to build what they say will be the largest decentralized single-cell immune dataset for juvenile dermatomyositis, a rare pediatric autoimmune disease. The effort combines at-home blood collection with community-funded research and could create a template for other rare disease studies.

Why it matters: - Juvenile dermatomyositis is a rare and serious pediatric autoimmune condition with limited research infrastructure. - The partnership is designed to generate high-quality immune data from children without requiring repeated clinic-based blood draws. - The project could become a model for studying other rare pediatric diseases.

What happened: - Molecule Science Foundation and O’Ryan Health announced a new research initiative on May 19, 2026. - The initiative aims to build the largest decentralized single-cell immune dataset for juvenile dermatomyositis. - The collaboration combines Molecule’s legal and technical infrastructure for community fundraising with O’Ryan Health’s Artemis Platform for decentralized sample collection. - The announcement came from Dover, Delaware.

The details: - Families will be able to collect small-volume blood samples at home using the RedDrop ONE device. - O’Ryan Health’s Artemis Platform converts those samples into single-cell RNA sequence data called “Immune Avatars.” - Those “Immune Avatars” are meant to act as a digital model of a child’s immune system. - Researchers will assemble disease insights as children move through symptom flare, therapy and therapy tapering. - The study is IRB-approved. - Molecule Science Foundation said the project is its first philanthropic deployment of the Coin-to-Company legal framework. - The framework is intended to give contributors a compliant pathway to support a US nonprofit, with potential tax advantages for donors. - Molecule Science Foundation is a Delaware nonprofit focused on decentralized biotechnology research and public science education. - O’Ryan Health focuses on at-home pediatric blood sampling and uses the Artemis Platform for logistics, informatics and compliant workflows. - Molecule’s broader mission centers on democratized funding and tokenization of intellectual property.

Between the lines: - The partnership is trying to solve two bottlenecks at once: access to pediatric samples and funding for rare disease research. - Decentralized collection may make it easier to enroll families who live far from specialty centers. - The use of a nonprofit funding framework suggests the project is being positioned as both a scientific and philanthropic pilot.

What’s next: - The partners will use the Artemis Platform to scale pediatric sample collection and data generation. - The dataset is expected to expand as more children move through care and provide samples over time. - The collaboration may inform future research programs for additional rare conditions.

The bottom line: - Molecule Science Foundation and O’Ryan Health are pairing at-home sample collection with new philanthropic infrastructure to accelerate rare pediatric disease research.